Pediatrix Medical Group Income Statement
MD / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.65 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $240.8M | $238.4M | $227.5M | $231.4M | $263.4M | $248.9M | $244.5M | $232.2M | $385.9M | $372.6M | $305.9M | $247.5M | $218.2M | $193.5M | $170.4M |
| Operating Income | $208.8M | -$68.7M | $7.3M | $172.7M | $202.9M | $98.1M | $171.8M | $248.4M | $454.9M | $571.7M | $557.9M | $513.0M | $452.1M | $389.5M | $355.4M |
| Interest Expense | - | - | $42.1M | $39.7M | $68.7M | $110.5M | $118.9M | $92.9M | $74.6M | $63.1M | $23.1M | $8.9M | $5.4M | $3.2M | $3.6M |
| Income Tax | $51.0M | -$2.3M | $12.0M | $18.8M | $27.2M | $16.7M | $16.6M | $44.7M | $80.2M | $189.2M | $204.0M | $191.4M | $167.9M | $147.3M | $135.2M |
| Net Income | $165.4M | -$99.1M | -$60.4M | $66.3M | $131.0M | -$796.5M | -$1.5B | $268.6M | $320.4M | $324.9M | $336.3M | $317.3M | $280.5M | $240.9M | $218.0M |
| EPS (Basic) | $1.97 | -$1.19 | -$0.73 | $0.79 | $1.54 | -$9.55 | -$17.94 | $2.95 | $3.47 | $3.52 | $3.61 | $3.22 | $2.83 | $2.47 | $2.28 |
| EPS (Diluted) | $1.94 | -$1.19 | -$0.73 | $0.79 | $1.53 | -$9.55 | -$17.83 | $2.93 | $3.45 | $3.49 | $3.58 | $3.18 | $2.78 | $2.42 | $2.23 |
| Shares Outstanding | 85.3M | 83.3M | 82.2M | 84.1M | 85.8M | 83.4M | 84.0M | 91.6M | 93.0M | 93.1M | 94.0M | 99.9M | 101.0M | 99.4M | 97.6M |